Octapharma Sweden

Octapharma Sweden company information, Employees & Contact Information

Octapharma is the world's largest privately-owned, independent company specializing in the field of blood plasma fractionation. With over 11,000 employees, we lead in the development and production of essential human proteins derived from human plasma and human cell lines. We support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Haematology, and Critical Care. Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 190 plasma donation centres across Europe and the US. 📍Octapharma Stockholm, Sweden • The only private owned manufacturer of blood plasma-based pharmaceuticals in the Nordics. • Pharmaceutical production, technology, quality assurance, supply chain, marketing, sales, and finance • Approximately 1000 employees in Stockholm Community guidelines: https://bit.ly/3M8ioml

Company Details

Employees
517
Founded
-
Address
Lars Forssells Gata 23, Stockholm,stockholm 11275,sweden
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Stockholm, Stockholm
Looking for a particular Octapharma Sweden employee's phone or email?

Octapharma Sweden Questions

News

Newly opened Kentwood plasma donation center helping save lives while providing income for donors - FOX 17 West Michigan News

Newly opened Kentwood plasma donation center helping save lives while providing income for donors FOX 17 West Michigan News

Octapharma Releases Results for Phase 3 Superiority Study of Pediatric Acute-onset Neuropsychiatric Syndrome - PR Newswire

Octapharma Releases Results for Phase 3 Superiority Study of Pediatric Acute-onset Neuropsychiatric Syndrome PR Newswire

Chair Denied, $11 M Verdict: Roque v. Octapharma - bamlawca.com

Chair Denied, $11 M Verdict: Roque v. Octapharma bamlawca.com

$2.55M Octapharma Plasma data breach class action settlement - Class Action Lawsuits

$2.55M Octapharma Plasma data breach class action settlement Class Action Lawsuits

Octapharma Reaches $2.55 Million Settlement Over Data Breach - Bloomberg Law News

Octapharma Reaches $2.55 Million Settlement Over Data Breach Bloomberg Law News

Octapharma Plasma opens in Springdale - Talk Business & Politics

Octapharma Plasma opens in Springdale Talk Business & Politics

Octapharma Plasma pauses operations at all sites nationwide - ABC30 Fresno

Octapharma Plasma pauses operations at all sites nationwide ABC30 Fresno

'Network issues' close Octapharma Plasma centers in Columbus and U.S. - The Columbus Dispatch

'Network issues' close Octapharma Plasma centers in Columbus and U.S. The Columbus Dispatch

Plasma donation center in Kentwood celebrates opening - woodtv.com

Plasma donation center in Kentwood celebrates opening woodtv.com

New Octapharma Plasma donation center opens in Visalia - KMPH

New Octapharma Plasma donation center opens in Visalia KMPH

ALN, Octapharma Plasma Agree to Settle Breach Lawsuits - Bank Info Security

ALN, Octapharma Plasma Agree to Settle Breach Lawsuits Bank Info Security

Plasma donation company Octapharma slowly reopening as BlackSuit gang claims attack - The Record from Recorded Future News

Plasma donation company Octapharma slowly reopening as BlackSuit gang claims attack The Record from Recorded Future News

Octapharma Plasma opens its first New York donation center in Amherst - Niagara Frontier Publications

Octapharma Plasma opens its first New York donation center in Amherst Niagara Frontier Publications

Octapharma USA: JAMA Publishes Results for Investigational Four-Factor Prothrombin Complex Concentrate in Cardiac Surgical Bleeding - PR Newswire

Octapharma USA: JAMA Publishes Results for Investigational Four-Factor Prothrombin Complex Concentrate in Cardiac Surgical Bleeding PR Newswire

New plasma donation center opens in southeast Fresno - ABC30 Fresno

New plasma donation center opens in southeast Fresno ABC30 Fresno

Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & Development - PR Newswire

Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & Development PR Newswire

Octapharma Plasma opens fourth Central California location - ABC30 Fresno

Octapharma Plasma opens fourth Central California location ABC30 Fresno

Octapharma Announces Availability of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures - PR Newswire

Octapharma Announces Availability of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures PR Newswire

Octapharma USA: FDA Grants Expanded Approval to wilate® as the First VWF Concentrate for Prophylaxis in All Types of VWD - PR Newswire

Octapharma USA: FDA Grants Expanded Approval to wilate® as the First VWF Concentrate for Prophylaxis in All Types of VWD PR Newswire

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, G - PR Newswire

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, G PR Newswire

Octapharma AG, CSL Behring LLC, and Grifols S.A. Lead the Global Plasma Protein Therapeutics Market - Yahoo Finance

Octapharma AG, CSL Behring LLC, and Grifols S.A. Lead the Global Plasma Protein Therapeutics Market Yahoo Finance

Octapharma to present new clinical data and studies at ASH 2022 to demonstrate its continued mission to meet the challenges faced by people with bleeding disorders - PR Newswire

Octapharma to present new clinical data and studies at ASH 2022 to demonstrate its continued mission to meet the challenges faced by people with bleeding disorders PR Newswire

Octapharma secures FDA nod for warfarin reversal agent Balfaxar - Fierce Pharma

Octapharma secures FDA nod for warfarin reversal agent Balfaxar Fierce Pharma

US firm Octapharma Plasma may have shut down US operations due to ransomware attack - Cyber Daily

US firm Octapharma Plasma may have shut down US operations due to ransomware attack Cyber Daily

Ransomware feared as IT 'issues' force Octapharma Plasma to close 150+ centers - theregister.com

Ransomware feared as IT 'issues' force Octapharma Plasma to close 150+ centers theregister.com

Octapharma | Biotechnology | The Pharmaletter - The Pharma Letter

Octapharma | Biotechnology | The Pharmaletter The Pharma Letter

Exclusive: BlackSuit ransomware gang claims hack on Octapharma Plasma - Cyber Daily

Exclusive: BlackSuit ransomware gang claims hack on Octapharma Plasma Cyber Daily

Octapharma's Prothrombin Complex Concentrate, Balfaxar®, Receives FDA Approval For Warfarin Reversal in Urgent Surgery & Invasive Procedures - PR Newswire

Octapharma's Prothrombin Complex Concentrate, Balfaxar®, Receives FDA Approval For Warfarin Reversal in Urgent Surgery & Invasive Procedures PR Newswire

How Did US FDA Get Octapharma To Drop Its Suit? - Citeline News & Insights

How Did US FDA Get Octapharma To Drop Its Suit? Citeline News & Insights

FDA Approves Octapharma’s cutaquig® 16.5% for Pediatric PI Patients, Providing Flexible Treatment Options - Business Wire

FDA Approves Octapharma’s cutaquig® 16.5% for Pediatric PI Patients, Providing Flexible Treatment Options Business Wire

New plasma donation center opens in southeast Fresno - yourcentralvalley.com

New plasma donation center opens in southeast Fresno yourcentralvalley.com

FDA Approves Octapharma’s Octagam® 10% for Adult Dermatomyositis - Business Wire

FDA Approves Octapharma’s Octagam® 10% for Adult Dermatomyositis Business Wire

Octapharma USA Sponsored Bombardier Blood Presented by Denver Mountain Climber During Special Hometown Screening - PR Newswire

Octapharma USA Sponsored Bombardier Blood Presented by Denver Mountain Climber During Special Hometown Screening PR Newswire

10% Receives 7 Years of Market Exclusivity for Adult Dermatomyositis - Business Wire

10% Receives 7 Years of Market Exclusivity for Adult Dermatomyositis Business Wire

FDA Approvals Strengthen Octapharma USA Pediatric Critical Care Product Portfolio - Business Wire

FDA Approvals Strengthen Octapharma USA Pediatric Critical Care Product Portfolio Business Wire

Octapharma Fingerprint Scan $9.9M Class Action Settlement - Class Action Lawsuits

Octapharma Fingerprint Scan $9.9M Class Action Settlement Class Action Lawsuits

Octapharma Group Reports Strong Results for 2018 - BioSpace

Octapharma Group Reports Strong Results for 2018 BioSpace

joliark restores abandoned stockholm brewery for octapharma - Designboom

joliark restores abandoned stockholm brewery for octapharma Designboom

Octapharma ordered to pay $105K after terminating worker who needed accommodation to care for cancer-stricken mom - HR Law Canada

Octapharma ordered to pay $105K after terminating worker who needed accommodation to care for cancer-stricken mom HR Law Canada

Octapharma Brewery / Joliark - ArchDaily

Octapharma Brewery / Joliark ArchDaily

Takeover by the major shareholder - Noerr

Takeover by the major shareholder Noerr

The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics - Wiley Online Library

The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics Wiley Online Library

Varifarma loses Octapharma licence - pharmabiz.net

Varifarma loses Octapharma licence pharmabiz.net

Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency in Patients With Haematological Malignancies - NTB Kommunikasjon

Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency in Patients With Haematological Malignancies NTB Kommunikasjon

Blood mafia investigation puts former Octapharma chief under house arrest - Portugal Resident

Blood mafia investigation puts former Octapharma chief under house arrest Portugal Resident

Octapharma Plasma Pay Chart (Up to $1,000 for New Donors in 2025) - MoneyPantry.com

Octapharma Plasma Pay Chart (Up to $1,000 for New Donors in 2025) MoneyPantry.com

Top Octapharma Sweden Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant